American Century Companies’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-32,676
| Closed | -$2.22M | – | 1601 |
|
|
2019
Q3 | $2.22M | Sell |
32,676
-68,284
| -68% | -$4.69M | ﹤0.01% | 957 |
|
|
2019
Q2 | $5.87M | Sell |
100,960
-38,662
| -28% | -$2.29M | 0.01% | 790 |
|
|
2019
Q1 | $9.78M | Buy |
139,622
+55,649
| +66% | +$4.13M | 0.01% | 628 |
|
|
2018
Q4 | $5.41M | Sell |
83,973
-6,833
| -8% | -$479K | 0.01% | 783 |
|
|
2018
Q3 | $6.38M | Buy |
90,806
+14,589
| +19% | +$853K | 0.01% | 797 |
|
|
2018
Q2 | $3.84M | Sell |
76,217
-131,123
| -63% | -$5.2M | ﹤0.01% | 897 |
|
|
2018
Q1 | $6.49M | Buy |
207,340
+12,837
| +7% | +$426K | 0.01% | 761 |
|
|
2017
Q4 | $6.65M | Buy |
194,503
+16,217
| +9% | +$517K | 0.01% | 782 |
|
|
2017
Q3 | $5.72M | Buy |
178,286
+50,992
| +40% | +$1.61M | 0.01% | 816 |
|
|
2017
Q2 | $4.14M | Buy |
127,294
+1,092
| +0.9% | +$34.6K | ﹤0.01% | 899 |
|
|
2017
Q1 | $3.97M | Sell |
126,202
-994
| -0.8% | -$29.4K | ﹤0.01% | 932 |
|
|
2016
Q4 | $3.74M | Buy |
127,196
+96,472
| +314% | +$2.94M | ﹤0.01% | 929 |
|
|
2016
Q3 | $889K | Buy |
30,724
+2,355
| +8% | +$65.6K | ﹤0.01% | 1183 |
|
|
2016
Q2 | $735K | Buy |
+28,369
| New | +$753K | ﹤0.01% | 1193 |
|
American Century Companies's GHDX Position: Q4 2019 in Review
American Century Companies sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 32,676 shares — an estimated $2.22M sold.
American Century Companies first reported a position in GHDX in Q2 2016 and held it in 14 quarters. The position peaked at $9.78M in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- American Century Companies reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- American Century Companies sold 32,676 Genomic Health, Inc. shares in Q4 2019, an estimated $2.22M.
- American Century Companies first reported a position in Genomic Health, Inc. in Q2 2016 and held it in 14 quarters.
- American Century Companies's Genomic Health, Inc. position peaked at $9.78M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on American Century Companies's 13F filing for Q4 2019, filed 12 Feb 2020.